Pro-tumorigenic Effects of miR-31 Loss in Mesothelioma
Sergey V. Ivanov(Bellevue Hospital Center), Harvey I. Pass(NYU Langone Health), Chandra Goparaju(New York University), Peter Lopez(New York University), Jiří Zavadil(Centre international de recherche sur le cancer), Ayelet Chajut(Rosetta Genomics (Israel)), Moshe Hoshen(University of Hawaiʻi at Mānoa), Shai Rosenwald(Rosetta Genomics (Israel)), Dalia Cohen(Regulus Therapeutics (United States)), Ginat Toren-Haritan(Rosetta Genomics (Israel))
Cited by 129
Related Papers
MicroRNAs accurately identify cancer tissue origin
|Nature Biotechnology|2008|987
Integrative Molecular Characterization of Malignant Pleural Mesothelioma
|Cancer Discovery|2018|630
Diagnostic Assay Based on hsa-miR-205 Expression Distinguishes Squamous From Nonsquamous Non–Small-Cell Lung Carcinoma
|Journal of Clinical Oncology|2009|410
Histone Deacetylase Inhibition Selectively Alters the Activity and Expression of Cell Cycle Proteins Leading to Specific Chromatin Acetylation and Antiproliferative Effects
|Journal of Biological Chemistry|1999|393
Design of a genome-wide siRNA library using an artificial neural network
|Nature Biotechnology|2005|386